section name header
Index
ACE Inhibitors and Angiotensin II Receptor Blockers for Diabetics with Microalbuminuria
ACE Inhibitors and Angiotensin Receptor Blockers for Progression of Non-Diabetic Renal Disease
Aldosterone Antagonists for Preventing the Progression of Chronic Kidney Disease
Angiotensin Receptor Blockers or Angiotensin Converting Enzyme Inhibitors in the Prevention of Atrial Fibrillation
Antihypertensive Agents for Preventing Diabetic Kidney Disease
Antihypertensive Treatment for Kidney Transplant Recipients
Antiproteinuric and Renoprotective Effects of ACE Inhibitors and Angiotensin II Receptor Blockers
Beta-Blockers Against other Antihypertensive Drugs
Beta-Blockers as Second-Line Therapy for Primary Hypertension
Beta-Blockers for Hypertension
Blood Pressure Lowering Efficacy of Renin Inhibitor Aliskiren for Primary Hypertension
Cardiology
Choice of Antihypertensive Drug in the Diabetic Patient from Prognostic Point of View
Cochrane review
Combining ACE Inhibitors and Angiotensin Receptor Blockers in Renal Disease
Corticosteroids in Iga Nephropathy
Dietary Sodium Restriction, Blood Pressure and Cardiovascular Morbidity
Drugs for Chronic Heart Failure with Preserved Ejection Fraction
Drug Treatment for Hypertension - Related Resources
Dual Alpha and Beta Blockers for Primary Hypertension
Evidence summary
Female
First-Line Renin Angiotensin System Inhibitors Versus other Drug Classes for Hypertension
Geriatrics
Internal medicine
Nsaids and Blood Pressure
Spironolactone for Hypertension
Systematic review
The Impact of Suppressing the Renin-Angiotensin System on Atrial Fibrillation
Trimethoprim or Trimethoprim-Sulfamethoxazole and Risk of Hyperkalaemia Among Patients Taking Renin-Angiotensin System Blockers
Trimethoprim-Sulfamethoxazole and Risk of Sudden Death Among Patients Taking Renin-Angiotensin System Blockers